UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

_________________________
FORM10-Q

_________________________
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended JanuaryOctober 31, 2018

2019

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to

__________

Commission file number0-5286

_________________________
KEWAUNEE SCIENTIFIC CORPORATION

(Exact name of registrant as specified in its charter)

_________________________
Delaware 38-0715562

(State or other jurisdiction of

incorporation or organization)

 

(IRS Employer

Identification No.)

2700 West Front Street

Statesville, North Carolina

 28677-2927
(Address of principal executive offices) (Zip Code)


Registrant’s telephone number, including area code:(704) 873-7202
Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading Symbol(s)Name of Exchange on which registered

Common Stock,$2.50 par value                 KEQU             NASDAQ Global Market
_________________________
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of RegulationS-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ☒    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, anon-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule12b-2 of the Exchange Act. (Check one):

Large accelerated filer   Accelerated filer 
Non-accelerated filer ☐ (Do not check if a smaller reporting company)  Smaller reporting company 
   Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant is a shell company (as defined by Rule12b-2 of the Exchange Act).    Yes  ☐    No  ☒

As of March 5, 2018,December 10, 2019, the registrant had outstanding 2,724,9322,750,143 shares of Common Stock.




KEWAUNEE SCIENTIFIC CORPORATION

INDEX TO FORM10-Q

FOR THE QUARTERLY PERIOD ENDED JANUARYOCTOBER 31, 2018

2019

i




Part 1. Financial Information

Item 1.Financial Statements


Kewaunee Scientific Corporation

Condensed Consolidated Statements of Operations

(Unaudited)

($ and shares in thousands, except per share data)

   Three months ended
January 31
  Nine months ended
January 31
 
   2018  2017  2018  2017 

Net sales

  $38,190  $30,371  $113,542  $103,979 

Costs of products sold

   29,836   25,339   90,456   84,704 
  

 

 

  

 

 

  

 

 

  

 

 

 

Gross profit

   8,354   5,032   23,086   19,275 

Operating expenses

   5,971   4,590   16,360   14,484 
  

 

 

  

 

 

  

 

 

  

 

 

 

Operating earnings

   2,383   442   6,726   4,791 

Other income

   179   120   524   358 

Interest expense

   (78  (71  (226  (229
  

 

 

  

 

 

  

 

 

  

 

 

 

Earnings before income taxes

   2,484   491   7,024   4,920 

Income tax expense

   1,566   133   3,149   1,695 
  

 

 

  

 

 

  

 

 

  

 

 

 

Net earnings

   918   358   3,875   3,225 

Less: net earnings attributable to the noncontrolling interest

   35   17   120   98 
  

 

 

  

 

 

  

 

 

  

 

 

 

Net earnings attributable to Kewaunee Scientific Corporation

  $883  $341  $3,755  $3,127 
  

 

 

  

 

 

  

 

 

  

 

 

 

Net earnings per share attributable to Kewaunee Scientific Corporation stockholders

     

Basic

  $0.32  $0.13  $1.38  $1.16 

Diluted

  $0.31  $0.13  $1.35  $1.15 

Weighted average number of common shares outstanding

     

Basic

   2,722   2,711   2,717   2,703 

Diluted

   2,784   2,734   2,772   2,724 

amounts)

 Three Months Ended
October 31,
 Six Months Ended
October 31,
 2019 2018 2019 2018
Net sales$39,722
 $37,278
 $79,058
 $79,430
Cost of products sold33,406
 29,614
 65,796
 64,183
Gross profit6,316
 7,664
 13,262
 15,247
Operating expenses6,355
 5,963
 12,525
 11,726
Operating earnings (loss)(39) 1,701
 737
 3,521
Other income16
 150
 72
 314
Interest expense, net(135) (91) (302) (182)
Earnings (loss) before income taxes(158) 1,760
 507
 3,653
Income tax expense2,003
 388
 2,172
 783
Net earnings (loss)(2,161) 1,372
 (1,665) 2,870
Less: net earnings attributable to the noncontrolling interest17
 40
 42
 49
Net earnings (loss) attributable to Kewaunee Scientific Corporation$(2,178) $1,332
 $(1,707) $2,821
Net earnings (loss) per share attributable to Kewaunee Scientific Corporation stockholders       
Basic$(0.79) $0.49
 $(0.62) $1.03
Diluted$(0.79) $0.48
 $(0.62) $1.01
Weighted average number of common shares outstanding       
Basic2,750
 2,743
 2,750
 2,740
Diluted2,750
 2,800
 2,750
 2,802









See accompanying notes to condensed consolidated financial statements.



Kewaunee Scientific Corporation

Condensed Consolidated Statements of Comprehensive Income

(Unaudited)

($ in thousands)

   Three months ended
January 31
  Nine months ended
January 31
 
   2018   2017  2018   2017 

Net earnings

  $918   $358  $3,875   $3,225 
  

 

 

   

 

 

  

 

 

   

 

 

 

Other comprehensive income (loss), net of tax:

       

Foreign currency translation adjustments

   203    (63  49    (232

Change in fair value of cash flow hedge

   12    35   30    53 
  

 

 

   

 

 

  

 

 

   

 

 

 

Other comprehensive income (loss)

   215    (28  79    (179
  

 

 

   

 

 

  

 

 

   

 

 

 

Comprehensive income, net of tax

   1,133    330   3,954    3,046 

Less: comprehensive income attributable to the noncontrolling interest

   35    17   120    98 
  

 

 

   

 

 

  

 

 

   

 

 

 

Comprehensive income attributable to Kewaunee Scientific Corporation

  $1,098   $313  $3,834   $2,948 
  

 

 

   

 

 

  

 

 

   

 

 

 

 Three Months Ended
October 31,
 Six Months Ended
October 31,
 2019 2018 2019 2018
Net earnings (loss)$(2,161) $1,372
 $(1,665) $2,870
Other comprehensive income (loss), net of tax:       
Foreign currency translation adjustments(179) (725) 17
 (1,113)
Change in fair value of cash flow hedge2
 1
 1
 5
Other comprehensive income (loss)(177) (724) 18
 (1,108)
Comprehensive income (loss), net of tax(2,338) 648
 (1,647) 1,762
Less: comprehensive income attributable to the noncontrolling interest17
 40
 42
 49
Comprehensive income (loss) attributable to Kewaunee Scientific Corporation$(2,355) $608
 $(1,689) $1,713





















See accompanying notes to condensed consolidated financial statements.



Kewaunee Scientific Corporation

Condensed Consolidated StatementStatements of Stockholders’ Equity

(Unaudited)

($ in thousands, except share and per share amounts)

   Common
Stock
   Additional
Paid-in
Capital
  Treasury
Stock
  Retained
Earnings
  Accumulated
Other
Comprehensive
Income (Loss)
  Total
Stockholders’
Equity
 

Balance at April 30, 2017

  $6,789   $2,695  $(53 $39,771  $(6,319 $42,883 

Net earnings attributable to Kewaunee Scientific Corporation

   —      —     —     3,755   —     3,755 

Other comprehensive income

   —      —     —     —     79   79 

Cash dividends paid, $0.49 per share

   —      —     —     (1,331  —     (1,331

Stock options exercised, 22,600 shares

   28    (20  —     —     —     8 

Stock based compensation

   4    272   —     —     —     276 
  

 

 

   

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Balance at January 31, 2018

  $6,821   $2,947  $(53 $42,195  $(6,240 $45,670 
  

 

 

   

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

 
Common
Stock
 
Additional
Paid-in
Capital
 
Treasury
Stock
 
Retained
Earnings
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Total
Stockholders’
Equity
Balance at April 30, 2019$6,875
 $3,133
 $(53) $43,552
 $(6,407) $47,100
Net earnings attributable to Kewaunee Scientific Corporation
 
 
 471
 
 471
Other comprehensive income
 
 
 
 195
 195
Cash dividends paid, $0.19 per share
 
 
 (522) 
 (522)
Stock based compensation9
 51
 
 
 
 60
Balance at July 31, 2019$6,884
 $3,184
 $(53) $43,501
 $(6,212) $47,304
Net earnings (loss) attributable to Kewaunee Scientific Corporation
 
 
 (2,178) 
 (2,178)
Other comprehensive income
 
 
 
 (177) (177)
Cash dividends paid, $0.19 per share
 
 
 (523) 
 (523)
Stock based compensation
 42
 
 
 
 42
Balance at October 31, 2019$6,884
 $3,226
 $(53) $40,800
 $(6,389) $44,468
 
Common
Stock
 
Additional
Paid-in
Capital
 
Treasury
Stock
 
Retained
Earnings
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Total
Stockholders’
Equity
Balance at April 30, 2018$6,841
 $3,006
 $(53) $43,836
 $(5,900) $47,730
Net earnings attributable to Kewaunee Scientific Corporation
 
 
 1,489
 
 1,489
Other comprehensive loss
 
 
 
 (384) (384)
Cash dividends paid, $0.17 per share
 
 
 (465) 
 (465)
Stock options exercised, 9,250 shares13
 (13) 
 
 
 
Stock based compensation7
 99
 
 
 
 106
Cumulative adjustment for ASC 606, net of tax
 
 
 217
 
 217
Balance at July 31, 2018$6,861
 $3,092
 $(53) $45,077
 $(6,284) $48,693
Net earnings attributable to Kewaunee Scientific Corporation$
 $
 $
 $1,332
 $
 $1,332
Other comprehensive loss
 
 
 
 (724) (724)
Cash dividends paid, $0.19 per share
 
 
 (521) 
 (521)
Stock options exercised, 5,800 shares8
 (8) 
 
 
 
Stock based compensation
 140
 
 
 
 140
Cumulative adjustment for ASC 606, net of tax
 
 
 671
 
 671
Balance at October 31, 2018$6,869
 $3,224
 $(53) $46,559
 $(7,008) $49,591





See accompanying notes to condensed consolidated financial statements.



Kewaunee Scientific Corporation

Condensed Consolidated Balance Sheets

($ and shares in thousands, except per share amounts)

   January 31,
2018
  April 30,
2017
 
   (Unaudited)    

Assets

   

Current Assets:

   

Cash and cash equivalents

  $9,178  $12,506 

Restricted cash

   1,493   1,435 

Receivables, less allowance; $224; $191, on each respective date

   30,843   29,889 

Inventories

   17,680   14,935 

Prepaid expenses and other current assets

   3,083   1,047 
  

 

 

  

 

 

 

Total Current Assets

   62,277   59,812 

Property, plant and equipment, at cost

   53,418   51,568 

Accumulated depreciation

   (39,588  (37,541
  

 

 

  

 

 

 

Net Property, Plant and Equipment

   13,830   14,027 

Deferred income taxes

   2,519   3,158 

Other

   4,068   3,919 
  

 

 

  

 

 

 

Total Other Assets

   6,587   7,077 
  

 

 

  

 

 

 

Total Assets

  $82,694  $80,916 
  

 

 

  

 

 

 

Liabilities and Equity

   

Current Liabilities:

   

Short-term borrowings and interest rate swaps

  $4,778  $3,591 

Current portion of long-term debt

   1,167   918 

Accounts payable

   12,631   11,995 

Employee compensation and amounts withheld

   2,848   2,765 

Deferred revenue

   1,959   5,806 

Other accrued expenses

   2,667   1,852 
  

 

 

  

 

 

 

Total Current Liabilities

   26,050   26,927 

Long-term debt

   1,556   2,431 

Accrued pension and deferred compensation costs

   8,509   8,301 

OtherNon-Current Liabilities

   486   —   
  

 

 

  

 

 

 

Total Liabilities

   36,601   37,659 

Commitments and Contingencies

   

Stockholders’ Equity:

   

Common Stock, $2.50 par value, Authorized – 5,000 shares; Issued – 2,728 shares; 2,715 shares; – Outstanding – 2,725 shares; 2,712 shares, on each respective date

   6,821   6,789 

Additionalpaid-in-capital

   2,947   2,695 

Retained earnings

   42,195   39,771 

Accumulated other comprehensive loss

   (6,240  (6,319

Common stock in treasury, at cost, 3 shares, on each date

   (53  (53
  

 

 

  

 

 

 

Total Kewaunee Scientific Corporation Stockholders’ Equity

   45,670   42,883 

Noncontrolling interest

   423   374 
  

 

 

  

 

 

 

Total Equity

   46,093   43,257 
  

 

 

  

 

 

 

Total Liabilities and Equity

  $82,694  $80,916 
  

 

 

  

 

 

 

 October 31,
2019
 April 30,
2019
 (Unaudited)  
Assets   
Current Assets:   
Cash and cash equivalents$7,647
 $10,647
Restricted cash1,951
 509
Receivables, less allowance; $427; $361, on each respective date32,017
 33,259
Inventories14,778
 17,206
Prepaid expenses and other current assets4,674
 3,736
Total Current Assets61,067
 65,357
Property, plant and equipment, at cost57,359
 56,676
Accumulated depreciation(41,475) (40,214)
Net Property, Plant and Equipment15,884
 16,462
Right of use assets10,082
 
Deferred income taxes102
 1,829
Other assets3,187
 3,575
Total Other Assets13,371
 5,404
Total Assets$90,322
 $87,223
Liabilities and Stockholders’ Equity   
Current Liabilities:   
Short-term borrowings and interest rate swaps$6,760
 $9,513
Current portion of long-term debt
 1,167
Current portion of capital lease liability18
 17
Current portion of operating lease liabilities1,401
 
Accounts payable13,836
 15,190
Employee compensation and amounts withheld3,788
 3,737
Deferred revenue2,032
 1,599
Other accrued expenses2,391
 1,510
Total Current Liabilities30,226
 32,733
Long-term debt
 97
Long-term portion of capital lease liability123
 132
Long-term portion of operating lease liabilities8,513
 
Accrued pension and deferred compensation costs5,592
 5,878
Other non-current liabilities878
 680
Total Liabilities45,332
 39,520
Commitments and Contingencies
 
Stockholders’ Equity:   
Common stock, $2.50 par value, Authorized – 5,000 shares; Issued – 2,753 shares; 2,750 shares; – Outstanding – 2,750 shares; 2,747 shares, on each respective date6,884
 6,875
        Additional paid-in-capital3,226
 3,133
Retained earnings40,800
 43,552
Accumulated other comprehensive loss(6,389) (6,407)
Common stock in treasury, at cost, 3 shares, on each date(53) (53)
Total Kewaunee Scientific Corporation Stockholders’ Equity44,468
 47,100
Noncontrolling interest522
 603
Total Stockholders’ Equity44,990
 47,703
Total Liabilities and Stockholders’ Equity$90,322
 $87,223
See accompanying notes to condensed consolidated financial statements.



Kewaunee Scientific Corporation

Condensed Consolidated Statements of Cash Flows

(Unaudited)

($ in thousands)

   Nine months ended
January 31
 
   2018  2017 

Cash flows from operating activities:

   

Net earnings

  $3,875  $3,225 

Adjustments to reconcile net earnings to net cash (used in) provided by operating activities:

   

Depreciation

   2,104   1,960 

Bad debt provision

   71   (42

Stock based compensation expense

   276   150 

Expense (benefit) for deferred income taxes

   639   (12

Change in assets and liabilities:

   

Increase (decrease) in receivables

   (1,025  2,090 

Increase in inventories

   (2,745  (105

Increase (decrease) in accounts payable and other accrued expenses

   2,020   (1,189

Decrease in deferred revenue

   (3,847  (237

Other, net

   (2,013  11 
  

 

 

  

 

 

 

Net cash (used in) provided by operating activities

   (645  5,851 

Cash flows from investing activities:

   

Capital expenditures

   (1,907  (2,190

Decrease (increase) in restricted cash

   (58  129 
  

 

 

  

 

 

 

Net cash used in investing activities

   (1,965  (2,061

Cash flows from financing activities:

   

Dividends paid

   (1,331  (1,163

Dividends paid to holders of noncontrolling interest in subsidiaries

   (74  —   

Proceeds from short-term borrowings

   44,639   39,804 

Repayments on short-term borrowings

   (43,452  (38,943

Payments on long-term debt

   (626  (316

Net proceeds from exercise of stock options

   8   141 
  

 

 

  

 

 

 

Net cash used in financing activities

   (836  (477

Effect of exchange rate changes on cash and cash equivalents

   118   (281
  

 

 

  

 

 

 

(Decrease) increase in cash and cash equivalents

   (3,328  3,032 

Cash and cash equivalents, beginning of period

   12,506   5,222 
  

 

 

  

 

 

 

Cash and cash equivalents, end of period

  $9,178  $8,254 
  

 

 

  

 

 

 

 Six Months Ended
October 31,
 2019 2018
Cash flows from operating activities:   
Net earnings (loss)$(1,665) $2,870
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:   
Depreciation1,292
 1,263
Bad debt provision72
 20
Stock based compensation expense115
 275
Provision for deferred income taxes1,727
 143
Change in assets and liabilities:   
Receivables1,171
 2,855
Inventories2,428
 565
Accounts payable and other accrued expenses(223) (4,202)
Deferred revenue433
 (321)
Other, net(854) (1,167)
Net cash provided by operating activities4,496
 2,301
Cash flows from investing activities:   
Capital expenditures(715) (1,311)
Net cash used in investing activities(715) (1,311)
Cash flows from financing activities:   
Dividends paid(1,045) (986)
Dividends paid to noncontrolling interest in subsidiaries(89) 
Proceeds from short-term borrowings31,456
 34,135
Repayments on short-term borrowings(34,209) (33,362)
Payments on long-term debt and lease obligations(1,273) (583)
Net proceeds from exercise of stock options(14) (29)
Net cash used in financing activities(5,174) (825)
Effect of exchange rate changes on cash and cash equivalents(165) (967)
Increase (decrease) in cash, cash equivalents and restricted cash(1,558) (802)
Cash, cash equivalents and restricted cash, beginning of period11,156
 10,958
Cash, cash equivalents and restricted cash, end of period$9,598
 $10,156











See accompanying notes to condensed consolidated financial statements.



Kewaunee Scientific Corporation

Notes to Condensed Consolidated Financial Statements

(unaudited)

A.Financial Information

The unaudited interim condensed consolidated financial statements of Kewaunee Scientific Corporation (the “Company”) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “Commission”). Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted, although the Company believes that the disclosures are adequate to make the information presented not misleading.

These interim condensed consolidated financial statements include all adjustments (consisting of normal recurring adjustments) necessary for a fair presentation of these financial statements and should be read in conjunction with the consolidated financial statements and notes included in the Company’s 20172019 Annual Report to Stockholders.on Form 10-K. The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full year. The condensed consolidated balance sheet as of April 30, 20172019 included in this interim period filing has been derived from the audited financial statements at that date, but does not include all of the information and related notes required by generally accepted accounting principles (GAAP)("GAAP") for complete financial statements.

The preparation of the interim condensed consolidated financial statements requires management to make certain estimates and assumptions that affect reported amounts and disclosures. Actual results could differ from those estimates.


B.Cash, Cash Equivalents and Restricted Cash
Cash and cash equivalents consist of cash on hand and highly liquid investments with original maturities of three months or less. During the periods ended October 31, 2019 and 2018, the Company had cash deposits in excess of FDIC insured limits. The Company has not experienced any losses from such deposits. Restricted cash includes bank deposits of subsidiaries used for performance guarantees against customer orders.
In accordance with ASU 2016-18, Statement of Cash Flows: Restricted Cash, the Company includes restricted cash along with the cash balance for presentation in the consolidated statements of cash flows. The reconciliation between the consolidated balance sheet and the consolidated statement of cash flows is as follows:
  October 31, 2019 October 31, 2018
Cash and cash equivalents $7,647
 $9,477
Restricted cash 1,951
 679
Total cash, cash equivalents and restricted cash $9,598
 $10,156

C. Revenue Recognition

Product sales

The Company recognizes revenue when control of a good or service promised in a contract (i.e., performance obligation) is transferred to a customer. Control is obtained when a customer has the ability to direct the use of and installation revenue are recognized whenobtain substantially all of the following criteria have been met: (1) products have been shipped,remaining benefits from that good or customers have purchased and accepted title to the goods, but because of construction delays, have requested that the Company temporarily store the finished goods on the customer’s behalf; service revenue for installation of products sold is recognized as the installation services are performed, (2) persuasive evidence of an arrangement exists, (3) the price to the customer is fixed, and (4) collectability is reasonably assured.service. The Company utilizes either the percentage of completion or completed contract method based on facts and circumstances of individual contracts.

Deferred revenue consists of customer deposits and advance billingsmajority of the Company’s products whererevenues are recognized over time as the customer receives control as the Company performs work under a contract. However, a portion of the Company’s revenues are recognized at a point-in-time as control is transferred at a distinct point in time per the terms of a contract.

Disaggregated Revenue
A summary of net sales transferred to customers at a point in time and over time for the periods ended October 31, 2019 and October 31, 2018 is as follows (in thousands):


 Three Months Ended October 31, 2019 Three months ended October 31, 2018
 Domestic International Total Domestic International Total
Over Time$29,950
 $8,138
 $38,088
 $28,311
 $6,656
 $34,967
Point in Time1,634
 
 1,634
 2,311
 
 2,311
 $31,584
 $8,138
 $39,722
 $30,622
 $6,656
 $37,278
 Six Months Ended October 31, 2019 Six Months Ended October 31, 2018
 Domestic International Total Domestic International Total
Over Time$58,185
 $18,187
 $76,372
 $62,559
 $12,738
 $75,297
Point in Time2,686
 
 2,686
 4,133
 
 4,133
 $60,871
 $18,187
 $79,058
 $66,692
 $12,738
 $79,430
Contract Balances
The closing and opening balances of contract assets arising from contracts with customers which were recorded as unbilled receivables were $5,116,000 at October 31, 2019 and $4,589,000 at April 30, 2019. The closing and opening balances of contract liabilities arising from contracts with customers were $2,032,000 at October 31, 2019 and $1,599,000 at April 30, 2019. The timing of revenue recognition, billings and cash collections results in accounts receivable, unbilled receivables, and deferred revenue which are disclosed on the consolidated balance sheets and in the notes to the consolidated financial statements. In general, the Company receives payments from customers based on a billing schedule established in its contracts. Unbilled receivables represent amounts earned which have not yet been recognized. Shippingbilled in accordance with contractually stated billing terms. Receivables are recorded when the right to consideration becomes unconditional and handling coststhe Company has a right to invoice the customer. Deferred revenue relates to payments received in advance of performance under the contract. Deferred revenue is recognized as revenue as (or when) the Company performs under the contract. Approximately all of the contract liability balances at April 30, 2019 and October 31, 2019 are expected to be recognized as revenue during the respective succeeding 12 months.
D. Inventories
The Company measures inventory using the first-in, first-out ("FIFO") method at the lower of cost and net realizable value. Inventories consisted of the following (in thousands):
 October 31, 2019 April 30, 2019
Finished products$3,068
 $4,139
Work in process1,878
 2,179
Raw materials9,832
 10,888
 $14,778
 $17,206
The Company’s International subsidiaries’ inventories were $2,005,000 at October 31, 2019 and $1,863,000 at April 30, 2019 and are included in coststhe above tables.


E. Fair Value of product sales. BecauseFinancial Instruments
The Company’s financial instruments consist primarily of the naturecash and quality of the Company’s products, any warranty issues are determined in a relatively short period after the sale and are infrequent in nature, and as such, warranty costs are immaterial to the Company’s consolidated financial position and results of operations and are expensed as incurred.

Product sales resulting from fixed-price construction contracts involve a signed contract for a fixed price to provide the Company’s laboratory furniture and fume hoods for a construction project. In these instances, the Company is usually in the role of a subcontractor, but in some cases may enter into a contract directly with theend-user of the products. Contract arrangements normally do not contain a general right of return relative to the delivered items. Product sales resulting from fixed-price construction contracts are generated from multiple-element arrangements that require separate units of accounting and estimates regarding the fairequivalents, mutual funds, cash surrender value of individual elements.life insurance policies, term loans and short-term borrowings. The Company has determined that its multiple-element arrangements that qualify as separate units of accounting are (1) product sales and (2) installation services. There is objective and reliable evidence of faircarrying value for both the product sales and installation services and allocation of arrangement consideration for each of these units is based onassets and liabilities approximate their relative fair values. Each of these elements represent individual units of accounting, as the delivered item has value to a customer on a stand-alone basis. The Company’s products are regularly sold on a stand-alone basis to customers which provides either best estimate of selling prices or vendor-specific objective evidence of fair value. The following tables summarize the Company’s fair value of installation services is separately calculated using expected costs of installation services. Many times thehierarchy for its financial assets and liabilities measured at fair value of installation services is calculated using price quotations from subcontractors to the Company who perform installation services on a stand-alone basis.

Product sales resulting from purchase orders involve a purchase order received by the Company from its dealers or stocking distributor. This category includes product sales for standard products,recurring basis as well as products which require some customization. Any customization requirements are approved by the customer prior to manufacture of the customized product. Sales from purchase orders are recognized under the terms of the purchase order which generally are freight on board (“FOB”) shipping pointOctober 31, 2019 and do not include rights of return. Accordingly, these sales are recognized at the time of shipment.

C.April 30, 2019 (in thousands):

  October 31, 2019
Financial Assets Level 1 Level 2 Total
Trading securities held in non-qualified compensation plans (1) $2,514
 $
 $2,514
Cash surrender value of life insurance policies (1) 
 76
 76
Total $2,514
 $76
 $2,590
Financial Liabilities      
Non-qualified compensation plans (2) $
 $3,007
 $3,007
Total $
 $3,007
 $3,007
  April 30, 2019
Financial Assets Level 1 Level 2 Total
Trading securities held in non-qualified compensation plans (1) $3,057
 $
 $3,057
Cash surrender value of life insurance policies (1) 
 76
 76
Total $3,057
 $76
 $3,133
Financial Liabilities      
Non-qualified compensation plans (2) $
 $3,519
 $3,519
Interest rate swap derivatives 
 1
 1
Total $
 $3,520
 $3,520
(1)The Company maintains two non-qualified compensation plans which include investment assets in a rabbi trust. These assets consist of marketable securities, which are valued using quoted market prices multiplied by the number of shares owned, and life insurance policies, which are valued at their cash surrender value.
(2)Plan liabilities are equal to the individual participants’ account balances and other earned retirement benefits.
F. Derivative Financial Instruments

The Company records derivatives on the condensed consolidated balance sheetsheets at fair value and establishes criteria for designation and effectiveness of hedging relationships. The nature of the Company’s business activities involves the management of various financial and market risks, including those related to changes in interest rates. The Company does not enter into derivative instruments for speculative purposes. In May 2013, the Company entered into an interest rate swap agreement whereby the interest rate payable by the Company on $3,450,000 of outstanding long-term debt was effectively converted to a fixed interest rate of 4.875% for the period beginning May 1, 2013 and ending August 1, 2017. In May 2013, the Company entered into an interest rate swap agreement whereby the interest rate payable by the Company on $2,600,000 of outstanding long-term debt was effectively converted to a fixed interest rate of 4.37% for the period beginning August 1, 2017 and ending May 1, 2020. In May 2013, the Company entered into an interest rate swap agreement whereby the interest rate payable by the Company on $1,218,000 of outstanding long-term debt was effectively converted to a fixed interest rate of 3.07% for the period beginning November 3, 2014 and ending May 1, 2020. The Company entered into these interest rate swap arrangements to mitigate future interest rate risk associated with its long-term debt and has designated these as cash flow hedges.

D. In September 2019, the Company terminated the interest rate swap arrangements in conjunction with the payoff of the outstanding long-term debt.


G. Long-term Debt and Other Credit Arrangements

At October 31, 2019, advances of $6.8 million were outstanding under the Company’s revolving credit facility, compared to advances of $9.5 million outstanding as of April 30, 2019. The Company had standby letters of credit outstanding of $344,000 at October 31, 2019 compared to standby letters of credit outstanding of $5.2 million at April 30, 2019. Amounts available under the $20 million revolving credit facility were $12.9 million and $5.3 million at October 31, 2019 and April 30, 2019, respectively.


At April 30, 2019, the Company was not in compliance with all of the financial covenants under the revolving credit facility. The Company received a waiver from its lender with respect to this noncompliance pursuant to a waiver letter executed on June 19, 2019 ("the Waiver Letter"). In connection with the Waiver Letter, the Company entered into a Security Agreement pursuant to which the Company granted a security interest in substantially all of its assets to secure its obligations under the Loan Agreement. On July 9, 2019, the Company entered into an amendment to the Loan Agreement and the Line of Credit to effect a change in the financial covenants set forth in the Loan Agreement.  This amendment did not change the amount of availability provided by the Company’s Line of Credit.

In September 2019, the Company paid off its term loan and terminated its interest rate swap agreements. On December 13, 2019, the Company entered into an amendment to the Loan Agreement and the Line of Credit to effect a change to an asset based lending arrangement based on eligible accounts receivable and inventory, with the available amount not to exceed $20 million through January 31, 2020, and with such maximum amount reduced to $15 million thereafter. This amendment replaced the prior financial covenants with new financial covenants, including minimum monthly liquidity and EBITDA requirements. Additionally, a requirement for the repatriation of foreign cash and restrictions on the payment of dividends were added. At October 31, 2019, the Company was in compliance with all of the then-applicable financial covenants of the agreement.

H. Leases

On May 1, 2019, the Company adopted Accounting Standards Update ("ASU") No. 2016-02, Leases, and all subsequently issued clarifying guidance. Under the new guidance, lessees are required to recognize lease assets and lease liabilities for the rights and obligations created by leased assets previously classified as operating leases. In July 2018, the Financial Accounting Standards Board ("FASB") issued ASU No. 2018-11, which permitted entities to record the impact of adoption using a modified retrospective method with any cumulative effect as an adjustment to retained earnings (accumulated deficit) as opposed to restating comparative periods for the effects of applying the new standard. The Company elected this transition approach; therefore, the Company’s prior period reported results are not restated to include the impact of this adoption. In addition, the Company elected the package of three transition practical expedients which alleviate the requirements to reassess embedded leases, lease classification and initial direct costs for leases that commenced prior to the adoption date. The Company has elected to use the short-term lease recognition exemption for all asset classes. This means, for those leases that qualify, the Company will not recognize right-of-use ("ROU") assets or lease liabilities, and this includes not recognizing ROU assets or lease liabilities for existing short-term leases of those assets. The adoption of this standard did not affect the Condensed Consolidated Statements of Operations and therefore, no cumulative effect adjustment was recorded. The adoption of this standard also did not materially affect the Condensed Consolidated Statements of Cash Flows.
The Company has operating type leases for real estate and equipment in both the U.S. and internationally and a financing lease for a truck in the U.S. At October 31, 2019, ROU assets totaled $10,082,000. Included in the ROU assets was a finance lease with a net value of $134,000 with accumulated amortization totaling $25,000. Operating cash paid to settle lease liabilities was $354,000 for the period ended October 31, 2019. The Company’s leases have remaining lease terms of up to 10 years, some of which may include options to extend the leases for up to 5 years or options to terminate the leases within 1 year. Operating lease expense was $576,000 for the three months ended October 31, 2019, inclusive of period cost for short-term leases, not included in lease liabilities, of $222,000. Operating lease expense was $1,125,000 for the six months ended October 31, 2019, inclusive of period cost for short-term leases, not included in lease liabilities, of $457,000.
At October 31, 2019, the weighted average remaining lease term for the capitalized operating leases was 8.0 years and the weighted average discount rate was 4.1%. For finance leases, the weighted average remaining lease term was 5.9 years and the weighted average discount rate was 10.0%. As most of the Company's leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company uses the implicit rate when readily determinable.


Future minimum lease payments of non-cancelable leases as of October 31, 2019:
  Operating Financing
Remainder of fiscal 2020 $853
 $16
2021 1,591
 32
2022 1,543
 32
2023 1,531
 32
2024 1,246
 31
Thereafter 5,198
 42
Total Minimum Lease Payments $11,962
 $185
Imputed Interest (2,049) (45)
Total $9,913
 $140
I. Earnings Per Share

Basic earnings per share is based on the weighted average number of common shares outstanding during the three and nine month periods.year. Diluted earnings per share reflects the assumed exercise of outstanding options and the conversion of restricted stock units and outstanding stock options(“RSUs”) under the Company’s Omnibus Incentive Plan,various stock compensation plans, except when such awardsRSUs and options have an anti-dilutiveantidilutive effect. There were 85,205 antidilutive RSUs and options outstanding at October 31, 2019. There were no antidilutive awardsRSUs or options outstanding at JanuaryOctober 31, 2018. The following is a reconciliation of basic to diluted weighted average common shares outstanding (in thousands):
 Three Months Ended October 31, Six Months Ended October 31, 
 20192018 20192018
      
Basic2,750
 2,743
  2,750
 2,740
 
Dilutive effect of stock options and RSUs
 57
  
 62
 
Weighted average common shares outstanding - diluted2,750
 2,800
  2,750
 2,802
 
J. Stock Options and Share-based Compensation
Compensation costs related to stock options and other stock awards granted by the Company are charged against operating expenses during their vesting period, under ASC 718, “Compensation-Stock Compensation”. The Company granted 36,534 RSUs under the 2017 Omnibus Incentive Plan in June 2019. The RSUs include both a service and a performance component, vesting over a three year period. The recognized expense is based upon the vesting period for service criteria and estimated attainment of the performance criteria at the end of the three-year period, based on the ratio of cumulative days incurred to purchase 39,200 sharestotal days over the three year period. The Company recorded share-based compensation expense during the three and six months ended October 31, 2019 of $41,000 and $82,000, respectively, with the remaining estimated share-based compensation expense of $512,000 to be recorded over the remaining vesting periods.
K. Income Taxes
Income tax expense of $2,003,000 and $388,000 was recorded for the three months ended October 31, 2019 and 2018, respectively. Income tax expense of $2,172,000 and $783,000 was recorded for the six months ended October 31, 2019 and 2018, respectively. The effective tax rates were not included1,267.7% and 22.0% for the three months ended October 31, 2019 and 2018, respectively. The effective tax rates were 428.4% and 21.4% for the six months ended October 31, 2019 and 2018, respectively. The increase in the computationeffective tax rate for the three-month and six-month periods is primarily due to the change in the Company’s assertion regarding the reinvestment of dilutedforeign unremitted earnings per shareand the impact of foreign earnings which are taxed at different tax rates than the US tax rate of 21%, and additional Global Intangible Low-Taxed Income ("GILTI") inclusion in the US.
Effective August 1, 2019, the Company elected to amend the indefinite reinvestment of foreign unremitted earnings position set forth by ASC 740-30-25-17 and dissolve the indefinite reinvestment of unremitted earnings assertion for the Singapore, China, and Kewaunee Labway India Pvt. Ltd. international subsidiaries.


The Company included a Dividend Distribution Tax withholding expense, imposed by the India Income Tax Department, at a rate of 20.6% for the three and nine monthsix months ended October 31, 2019. This expense was comprised of $353,000 of taxes paid for the Kewaunee Labway India Pvt. Ltd. dividend distribution that was paid to the parent company and a $1,730,000 deferred tax liability for the global tax exposure related to all remaining historical unremitted earnings of these international subsidiaries as of October 31, 2019. The Company recorded all deferred tax assets and liabilities related to its outside basis differences in its foreign subsidiaries consistent with ASC 740.
L. Defined Benefit Pension Plans
The Company has non-contributory defined benefit pension plans covering substantially all domestic salaried and hourly employees. These plans were amended as of April 30, 2005; no further benefits have been, or will be, earned under the plans, subsequent to the amendment date, and no additional participants will be added to the plans. There were no Company contributions paid to the plans during the three and six months ended October 31, 2019, and the Company does not expect any contributions to be paid during the remainder of the fiscal year. Contributions of $1,000,000 were paid to the plans during the six months ended October 31, 2018. The Company assumed an expected long-term rate of return of 7.75% for the periods ended JanuaryOctober 31, 2017, because the option exercise prices were greater than the average market price of the common shares during the quarter,2019 and accordingly, such stock options would have an antidilutive effect.

E.Inventories

InventoriesOctober 31, 2018. Pension expense consisted of the following (in thousands):

   January 31, 2018   April 30, 2017 

Finished products

  $3,778   $3,179 

Work in process

   2,133    1,950 

Raw materials

   11,769    9,806 
  

 

 

   

 

 

 
  $17,680   $14,935 
  

 

 

   

 

 

 

The Company uses the

 Three Months Ended October 31, 2019 Three Months Ended October 31, 2018
Service cost$0
 $0
Interest cost208
 215
Expected return on plan assets(355) (362)
Recognition of net loss260
 221
Net periodic pension expense$113
 $74
 Six Months Ended October 31, 2019 Six Months Ended October 31, 2018
Service cost$0
 $0
Interest cost416
 430
Expected return on plan assets(710) (724)
Recognition of net loss520
 442
Net periodic pension expense$226
 $148
last-in,first-outM. (LIFO) method of valuing inventory for its domestic operations, which represents $15,833,000 of inventory at January 31, 2018 and $12,730,000 at April 30, 2017. An actual valuation of inventory under the LIFO method can be made only at the end of each year based on the inventory levels and costs at that time. Interim LIFO calculations are based on management’s estimates of expectedyear-end inventory levels and costs, and are subject to the finalyear-end LIFO inventory valuation. The Company’s international subsidiaries’ inventories were $1,847,000 at January 31, 2018 and $2,205,000, at April 30, 2017, measured using thefirst-in,first-out (“FIFO”) method at the lower of cost and net realizable value.

F.Segment Information

The Company’s operations are classified into two business segments: Domestic and International. The Domestic business segment principally designs, manufactures, and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, worksurfaces, workstations, workbenches, and computer enclosures. The International business segment, which consists of the Company’s foreign subsidiaries, provides products and services, including facility design, detailed engineering, construction, and project management from the planning stage through testing and commissioning of laboratories. Intersegment transactions are recorded at normal profit margins. All intercompany balances and transactions have been eliminated. Certain corporate expenses shown below have not been allocated to the business segments.

The following table providestables provide financial information by business segments for the threeperiods ended October 31, 2019 and nine months ended January 31, 2018 and 2017 (in thousands):

   Domestic
Operations
   International
Operations
   Corporate /
Eliminations
   Total 

Three months ended January 31, 2018

        

Revenues from external customers

  $29,734   $8,456   $—     $38,190 

Intersegment revenues

   1,145    1,361    (2,506   —   

Earnings (loss) before income taxes

   2,959    1,363    (1,838   2,484 

Three months ended January 31, 2017

        

Revenues from external customers

  $25,313   $5,058   $—     $30,371 

Intersegment revenues

   344    538    (882   —   

Earnings (loss) before income taxes

   563    943    (1,015   491 
   Domestic
Operations
   International
Operations
   Corporate/
Eliminations
   Total 

Nine months ended January 31, 2018

        

Revenues from external customers

  $80,420   $33,122   $—     $113,542 

Intersegment revenues

   10,298    3,291    (13,589   —   

Earnings (loss) before income taxes

   7,720    4,019    (4,715   7,024 

Nine months ended January 31, 2017

        

Revenues from external customers

  $83,161   $20,818   $—     $103,979 

Intersegment revenues

   3,781    2,936    (6,717   —   

Earnings (loss) before income taxes

   5,580    3,010    (3,670   4,920 

G.Defined Benefit Pension Plans

 
Domestic
Operations
 
International
Operations
 
Corporate /
Eliminations
 Total
Three months ended October 31, 2019       
Revenues from external customers$31,584
 $8,138
 $
 $39,722
Intersegment revenues907
 641
 (1,548) 
Earnings (loss) before income taxes$746
 $501
 $(1,405) $(158)
Three months ended October 31, 2018       
Revenues from external customers$30,622
 $6,656
 $
 $37,278
Intersegment revenues416
 1,108
 (1,524) 
Earnings (loss) before income taxes$2,837
 $705
 $(1,782) $1,760



 
Domestic
Operations
 
International
Operations
 
Corporate /
Eliminations
 Total
Six months ended October 31, 2019       
Revenues from external customers$60,871
 $18,187
 $
 $79,058
Intersegment revenues3,086
 1,483
 (4,569) 
Earnings (loss) before income taxes$2,306
 $1,109
 $(2,908) $507
Six months ended October 31, 2018       
Revenues from external customers$66,692
 $12,738
 $
 $79,430
Intersegment revenues878
 1,834
 (2,712) 
Earnings (loss) before income taxes$5,945
 $1,154
 $(3,446) $3,653
N. Reclassifications
During the second quarter of fiscal year 2019, the Company changed its method of accounting for its Domestic segment’s inventory from the LIFO method to the FIFO method.  The Company hasnon-contributory defined benefit pension plans covering substantially all domestic salaried and hourly employees. These plans were amended asreclassified certain amounts in the condensed consolidated statements of April 30, 2005; no further benefits have been, or will be, earned underoperations, the plans, subsequent tocondensed consolidated statements of comprehensive income, the amendment date, and no additional participants will be added to the plans. Company contributionscondensed consolidated statements of $600,000 were paid to the plans during the nine months ended January 31, 2018,stockholders’ equity and the Company does not expect any contributions to be paid to the plans during the remaindercondensed consolidated statements of the fiscal year. Contributions of $555,000 were paid to the plans during the nine months ended January 31, 2017. The Company assumed an expected long-term rate of return of 7.75%cash flows for the six-month period ended JanuaryOctober 31, 2018 as compared to 8.0% for the period ended January 31, 2017. Pension expense consisted of the following (in thousands):

   Three months ended
January 31, 2018
   Three months ended
January 31, 2017
 

Service cost

  $-0-   $-0- 

Interest cost

   219    232 

Expected return on plan assets

   (328   (311

Recognition of net loss

   283    314 
  

 

 

   

 

 

 

Net periodic pension expense

  $174   $235 
  

 

 

   

 

 

 

   Nine months ended
January 31, 2018
   Nine months ended
January 31, 2017
 

Service cost

  $-0-   $-0- 

Interest cost

   687    695 

Expected return on plan assets

   (984   (932

Recognition of net loss

   849    942 
  

 

 

   

 

 

 

Net periodic pension expense

  $522   $705 

H.Fair Value of Financial Instruments

The Company’s financial instruments consist primarily of cash and equivalents, mutual funds, cash surrender value of life insurance policies, term loans and short-term borrowings. The carrying value of these assets and liabilities approximate their fair value. The following tables summarize the Company’s fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of January 31, 2018 and April 30, 2017 (in thousands):

   January 31, 2018 
   Level 1   Level 2   Total 

Financial Assets

      

Trading securities held innon-qualified compensation plans (1)

  $3,994   $—     $3,994 

Cash surrender value of life insurance policies (1)

   —      75    75 
  

 

 

   

 

 

   

 

 

 

Total

  $3,994   $75   $4,069 
  

 

 

   

 

 

   

 

 

 

Financial Liabilities

      

Non-qualified compensation plans (2)

  $—     $4,472   $4,472 

Interest rate swap derivatives

   —      14    14 
  

 

 

   

 

 

   

 

 

 

Total

  $—     $4,486   $4,486 
  

 

 

   

 

 

   

 

 

 
   April 30, 2017 
   Level 1   Level 2   Total 

Financial Assets

      

Trading securities held innon-qualified compensation plans (1)

  $3,748   $—     $3,748 

Cash surrender value of life insurance policies (1)

   —      75    75 
  

 

 

   

 

 

   

 

 

 

Total

  $3,748   $75   $3,823 
  

 

 

   

 

 

   

 

 

 

Financial Liabilities

      

Non-qualified compensation plans (2)

  $—     $4,186   $4,186 

Interest rate swap derivatives

   —      62    62 
  

 

 

   

 

 

   

 

 

 

Total

  $—     $4,248   $4,248 
  

 

 

   

 

 

   

 

 

 

(1)The Company maintains twonon-qualified compensation plans which include investment assets in a rabbi trust. These assets consist of marketable securities, which are valued using quoted market prices multiplied by the number of shares owned, and life insurance policies, which are valued at their cash surrender value.
(2)Plan liabilities are equal to the individual participants’ account balances and other earned retirement benefits.

I.Share-based Compensation

The stockholders approved the 2017 Omnibus Incentive Plan (“2017 Plan”) on August 30, 2017, which enables the Company to grant a broad range of equity, equity-related, andnon-equity types of awards, with potential recipients including directors, consultants and employees. This plan replaces the 2010 Stock Option Plan for Directors and the 2008 Key Employee Stock Option Plan. No new awards will be granted under the prior plans. All outstanding options granted under the prior plans will remain subject to the prior plans. At the date of approval of the 2017 Plan there were 280,100 shares available for issuance under the prior plans. These shares and any outstanding awards that subsequently cease to be subject to such awards are available under the 2017 Plan. The 2017 Plan did not increase the total number of shares available for issuance under the Company’s equity compensation plans.

The Company issued restricted stock units (“RSUs”) under the 2017 Plan and recorded stock-based compensation expense of $60,000 and $100,000 during the three and nine months ended January 31, 2018 in accordance with ASC 718, “Compensation—Stock Compensation.” The RSUs include both a service and performance component vesting over a three year period. The recognized expense is based upon the vesting period for service criteria and estimated attainment of the performance criteria at the end of the three year period based on cumulative days incurred and remaining over the three year period. The remaining estimated compensation expense of $510,000 will be recorded over the remaining three year period.

J.Income Taxes

On December 22, 2017, the Tax Cuts and Jobs Act (the ��2017 Tax Act”) was signed into law. The 2017 Tax Act includes a broad range of tax reform provisions affecting businesses, including lower corporate tax rates, changes in business deductions, and international tax provisions. In response to the 2017 Tax Act, the U.S. Securities and Exchange Commission staff issued Staff Accounting Bulletin No. 118 (“SAB 118”) to address the application of U.S. GAAP in situations where a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the 2017 Tax Act. SAB 118 provides that the measurement period is complete when a company’s accounting is complete and that the measurement period shall not extend beyond one year from the enactment date. SAB 118 provides guidance for registrants under three scenarios: (i) measurement of certain income tax effects is complete, (ii) measurement of certain income tax effects can be reasonably estimated, and (iii) measurement of certain income tax effects cannot be reasonably estimated.

The 2017 Tax Act lowered the federal statutory tax rate from 35% to 21%. As the Company has a fiscal year ending April 30, it is subject to a blended tax rate for the current fiscal year. Therefore, a blended rate of 29.73% was computed as the federal statutory rate for this year.

The Company has analyzed the income tax effects of the 2017 Tax Act and determined that (ii) measurement of the income tax effects can be reasonably estimated, and, as such, provisional amounts have been recorded. The Company believes that all provisional amounts reflected in its financial statements are based on the best estimates that can be made at this time. The Company will continue to analyze all impacts of the 2017 Tax Act and will update provisional amounts as required. The Company recognized income tax expense of $1,566,000 and $3,149,000 for the three and nine months ended January 31, 2018. The effective tax rate was 63.0% and 44.8% for the three and nine months ended January 31, 2018.

In accordance with ASC 740, ”Income Taxes”, which requires deferred taxes to bere-measured in the year of an income tax rate change, the Company recorded a provisional discrete deferred income tax expense of $587,000 in the three months ended January 31, 2018 as a result of applying a lower U.S. federal income tax rate to the Company’s net deferred tax assets.

The Company revalued the U.S. deferred tax balances based on the tax rates effective for the following fiscal year at the new federal rate of 21% for amounts that are not expected to reverse during the current fiscal year and revalued the deferred tax balances expected to reverse in the current fiscal year at the Company’s current fiscal year blended rate of 29.73%. The Company has not yet completed the revaluation of the deferred tax balances due to estimates which are being used during interim periods until finalization of the balances can occur at the Company’s fiscal year end.

The 2017 Tax Act also includes aone-time transition tax on accumulated unrepatriated foreign earnings. In the three months ended January 31, 2018, the Company recorded a provisional discrete current income tax expense of $528,000 on accumulated unrepatriated foreign earnings, including estimates for foreign earnings through April 30, 2018. In addition, the Company has not yet completed the calculation of the related income tax pools for its foreign subsidiaries. The Company is entitled to elect to pay theone-time transition tax over a period of eight years. The Company intends to make this election and has recorded $486,000 of the provisional expense as othernon-current liabilities in the Company’s Consolidated Balance Sheet for January 31, 2018. No additional income taxes have been provided for any remaining undistributed foreign earnings not subject to the transition tax, or any additional outside basis difference inherent in these entities, as these amounts continue to be indefinitely reinvested in foreign operations.

The Company is currently in the process of evaluating the new Global IntangibleLow-Taxed Income (“GILTI”) provisions and has not yet elected an accounting policy with respect to whether to reflect GILTI in its deferred tax calculations or not. Therefore, the Company has not made any adjustments related to the GILTI tax in its financial statements. Under the SEC guidance noted above, the Company will continue to analyze and assess the effects of the GILTI provisions of the Act.

The Company anticipates future impacts at a U.S., state and local tax level related to the 2017 Tax Act as statutory and interpretive guidance is not available from applicable tax authorities needed to reasonably estimate the impact. Consequently, the Company has not recorded provisional amounts for this statutory and interpretive guidance and has continued to apply ASC 740 based on the provisions of the tax laws that were in effect immediately prior to the 2017 Tax Act enactment.

K.Reclassifications

Certain 2017 amounts have been reclassified to conform to the 2018 presentation in the consolidated statements of cash flows. Such reclassifications had no impact on net earnings.

L.current period format.

O. New Accounting Standards

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update2014-09, “Revenue from Contracts with Customers” (“ASU2014-09”). This update outlines a new comprehensive revenue recognition model that supersedes most current revenue recognition guidance and requires companies to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU2014-09 also requires additional disclosures about the nature, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments. The FASB has issued several updates and/or practical expedients to ASU2014-09. ASU2014-09 and the subsequent updates and/or practical expedients to the standard will be effective for the Company during the first quarter of our fiscal year 2019 and we do not plan to early adopt. ASU2014-09 provides two methods of adopting the standard: using either a full retrospective approach or modified retrospective approach. We expect to elect the modified retrospective approach of adopting the standard. We have conducted an assessment of how ASU2014-09 is likely to affect us, identifying the Company’s revenue streams and performance obligations. Our contracts with customers currently may be for single performance obligations or for multiple performance obligations. Based on our assessment, we do not believe the new standard significantly changes our accounting policy for these types of performance obligations. We have also evaluated the impact the new standard will have on our existing policies, contracts, accounting processes, internal controls, reporting systems and disclosure processes. We have begun implementing improvements and or enhancements to our business processes to support the implementation of the standard. We currently have not identified an improvement or enhancement that we would conclude would be a significant change to our internal control environment. Based on the evaluation and implementation efforts completed to date, we believe the adoption of ASU2014-09 will not have a significant impact on the Company’s consolidated financial position, results of operations, equity or cash flows.

In July 2015,February 2016, the FASB issued ASU2015-11, “Inventory – Simplifying the Measurement of Inventory. 2016-2, “Leases.” This guidance changesestablishes a ROU model that requires a lessee to record a ROU asset and a lease liability on the measurement principlebalance sheet for inventory fromall leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the lowerpattern of cost or market to the lower of cost and net realizable value. Net realizable value is defined as estimated selling pricesexpense recognition in the ordinary courseincome statement. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of business, less reasonably predictable costs of completion, disposal, and transportation.the earliest comparative period presented in the financial statements, with certain practical expedients available. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2016.2018. The Company adopted this standard effective May 1, 2017.2019. See Note H for a discussion of the impact of adoption of this standard.

In August 2018, the Commission adopted final rules pursuant to Commission Release No. 33-10532, “Disclosure Update and Simplification,” amending certain disclosure requirements that were redundant, duplicative, overlapping, outdated or superseded. In addition, the amendments expanded the disclosure requirements relating to the analysis of stockholders’ equity for interim financial statements. Under the amendments, an analysis of changes in each caption of stockholders’ equity presented in the balance sheet must be provided in a note or separate statement. The analysis should present a reconciliation of the beginning balance to the ending balance of each period for which a statement of income is required to be filed. This final rule became effective on November 5, 2018. The Company adopted this final rule effective for the second quarter of fiscal 2019. The adoption of this standard did not have a significant impact on the Company’s consolidated financial position or results of operations.

In MarchFebruary 2018, the FASB issued ASU 2018-2, “Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income.” This guidance provides the Company with an option to reclassify stranded tax effects resulting from the Tax Cuts and Jobs Act (the "2017 Tax Act") from accumulated other comprehensive income to retained earnings. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018, with early adoption permitted. The Company adopted this standard effective May 1, 2019 and did not elect to reclassify tax effects as a result of tax reform; therefore, the adoption did not have a significant impact on the Company’s consolidated financial position or results of operations.
In June 2016, the FASB issued ASU2016-9, “Stock Compensation – Improvements to Employee Share-Based Payment Accounting. 2016-13, “Measurement of Credit Losses on Financial Instruments,This guidance simplifies various aspects related to how share-based payments are accountedwhich replaces the current incurred loss method used for and presented in thedetermining credit losses on financial statements.assets, including trade receivables, with an expected credit loss method. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2016.2022. The Company adoptedwill adopt this standard prospectively effective May 1, 2017. Prior periods werein fiscal year 2024. The Company does not retrospectively adjusted. Theexpect the adoption of this standard did notto have a significant impact on the Company’s consolidated financial position or results of operations.

P. Subsequent Events


In December 2019, the Company initiated a restructuring, which included the addition of a new Vice President of Information Technology to lead the transformation and modernization of the Company's information systems, and a reduction in workforce primarily in its domestic operations to reduce operating expenses on an ongoing basis. This restructuring also included a plan for closure of the Company’s subsidiary in China, a commercial sales organization for the Company’s products in China. The Company expects to record a charge in the range of $385,000 to $535,000 in the third quarter of fiscal year 2020 as a result of the restructuring consisting primarily of hiring and relocation expenses and one-time termination benefits for employee severance and benefits. The majority of these expenses are expected to be paid during the third quarter of fiscal year 2020.

Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations

The Company’s 20172019 Annual Report to Stockholders contains management’s discussion and analysis of the Company’s financial condition and results of operations as of and for the year ended April 30, 2017.2019. The following discussion and analysis describes material changes in the Company’s financial condition since April 30, 2017.2019. The analysis of results of operations compares the three and ninesix months ended JanuaryOctober 31, 20182019 with the comparable periods of the prior year.

Results of Operations

Sales for the three months ended January 31, 2018quarter were $38,190,000, an$39,722,000, a 6.6% increase of 25.7% from sales of $30,371,000$37,278,000 in the comparable period of the prior year. Domestic sales for the quarter were $29,734,000, an increase of 17.5%$31,584,000, up 3.1% from sales of $25,313,000$30,622,000 in the comparable period of the prior year. International sales for the quarter were $8,456,000, an increase of 67.2%$8,138,000, up 22.3% from sales of $5,058,000$6,656,000 in the comparable period of the prior year.  The increase in Domestic sales for the quarter was due to strengtha result of increased activity in the laboratory, healthcare, and technical furniture productsCompany's direct sales markets offsetting weakness in dealer activity. International sales increased year over year as a result of continued deliveries of a large, strategic order in the US, Middle East, Indian and Asian markets with sales in each of these markets exceeding the prior period third quarter.

East. 

Sales for the ninesix months ended JanuaryOctober 31, 20182019 were $113,542,000, an increase of 9.2%$79,058,000, a 0.5% decrease from sales of $103,979,000$79,430,000 in the comparable period of the prior year. Domestic sales for the six-month period were $80,420,000,$60,871,000, down 8.7% from $83,161,000sales of $66,692,000 in the comparable period of the prior year, as domestic orders from dealers were lower than the prior year period.year.  International sales for the quarter were $33,122,000,$18,187,000, up 42.8% from sales of $20,818,000$12,738,000 in the comparable period of the prior year due to the impact of a large order being delivered to a customer in the Middle East.

year. 

The Company’s order backlog was $116.1$92 million at JanuaryOctober 31, 2018,2019, as compared to $113.5$101 million at October 31, 2018, and $101 million at April 30, 20172019. The Company continues to have a strong volume of outstanding quotations globally and $106.9 million at January 31, 2017. Incoming orders continued to be strong in all of the Company’s key markets, increasing the order backlog year-over-year.

is aggressively pursuing these projects.

The gross profit margin for the three months ended JanuaryOctober 31, 20182019 was 21.9%15.9% of sales, as compared to 16.6%20.6% of sales in the comparable quarter of the prior year. The increase in the gross profit margin percent was primarily due to improved operating leverage from the increased sales volume as well as more profitable product mix than in the prior third quarter.

The gross profit margin for the ninesix months ended JanuaryOctober 31, 20182019 was 14.4%16.8% of sales, as compared to 13.9%19.2% of sales in the comparable period of the prior year. The increasedecrease in the gross profit margin percentpercentage for the three and six months ended October 31, 2019 was primarily due to continued executiona result of a number of low margin orders that the Company’s cost reductionCompany aggressively pursued and productivity improvement programs,secured over the past year, and a favorable shift in product mix.

strategic Middle East order aggressively secured over two years ago at lower than normal margins.

Operating expenses for the three months ended JanuaryOctober 31, 20182019 were $5,971,000,$6,355,000, or 15.6%16.0% of sales, as compared to $4,590,000,$5,963,000, or 15.1%16.0% of sales, in the comparable period of the prior year. Operating expenses for the six months ended October 31, 2019 were $12,525,000, or 15.8% of sales, as compared to $11,726,000, or 14.8% of sales, in the comparable period of the prior year. The increase in operating expenses for the three and six months ended JanuaryOctober 31, 20182019 related primarily to increases in marketing expense of $89,000, compensation expense of $483,000, bad debt expense of $91,000, Internationalhigher operating expenses of $267,000, corporate governance expenses of $81,000 and professional services $194,000, partially offset by a decrease in pension expense of $61,000.

Operating expenses for the nine months ended January 31, 2018 were $16,360,000, or 14.4% of sales, as compared to $14,484,000, or 13.9% of sales,costs in the comparable period ofinternational segment as the prior year. The increaseCompany made investments in operating expenses forcapabilities intended to strengthen its position in the nine months ended January 31, 2018 related primarily to increases in marketing expense of $144,000, compensation expense of $676,000, bad debt expense of $113,000, International operating expenses of $432,000, corporate governance expenses of $319,000 and professional services of $78,000, partially offset by a decrease in pension expense $183,000.

India market.

Interest expense was $78,000$135,000 and $226,000$302,000 for the three and ninesix months ended JanuaryOctober 31, 2018,2019, as compared to $71,000$91,000 and $229,000$182,000 for the comparable periods of the prior year. The changes in interest expense in the current three and nine month periods were primarily attributable to changes in the borrowing levels.

Income tax expense of $1,566,000$2,003,000 and $133,000$388,000 was recorded for the three months ended JanuaryOctober 31, 2019 and 2018, respectively. For the six months ended October 31, 2018 and 2017,2019, income tax expense was $2,172,000 and $783,000, respectively. The effective tax rates were 63.0%1,267.7% and 27.1%22.0% for the three months ended JanuaryOctober 31, 20182019 and 2017, respectively. Our effective tax rate increased in the third quarter of fiscal year 2018, compared to the prior year period, primarily due to the effect of the enactment of the Tax Cuts and Jobs Act, which was signed into law on December 22, 2017. Two provisions of the new law had an immediate impact. First, the U.S. corporate tax rate was reduced from 35% to 21%. This rate reduction required the Company tore-measure our net deferred tax assets assuming a future tax benefit at the new lower 21% rate. The estimated discrete impact of this re-measurement of our net deferred tax assets recorded for the three months ended January 31, 2018 was $587,000. Second, as part of the transition to a modified territorial system, the new law imposes aone-time transition tax on the unremitted earnings of our foreign subsidiaries. The estimated discrete impact of thisone-time transition tax recorded for the three months ended January 31, 2018 was $528,000. The Company intends to elect to pay this tax over an8-year period.

Income tax expense of $3,149,000 and $1,695,000 was recorded for the nine months ended January 31, 2018 and 2017, respectively. The effective tax rates were 44.8%428.4% and 34.5%21.4% for the ninesix months ended JanuaryOctober 31, 2019 and 2018, respectively. The increase in the effective tax rate for the three-month and 2017, respectively.

six-month periods reflects the impact of foreign earnings which were taxed at different tax rates than the US tax rate of 21% and additional GILTI inclusion in the US.



As part the Company’s revised global treasury management strategy, the Company elected to amend the indefinite reinvestment of foreign unremitted earnings position set forth by ASC 740 and dissolve the indefinite reinvestment of unremitted earnings assertion for the Singapore, China, and Kewaunee Labway India Pvt. Ltd. international subsidiaries. Revoking this election provides the Company more flexibility in treasury management to invest in projects intended to improve the Company’s operating performance.
The Company included a Dividend Distribution Tax withholding expense, imposed by the India Income Tax Department, at a rate of 20.6% for the three and six months ended October 31, 2019. This expense was comprised of $353,000 of taxes paid for the Kewaunee Labway India Pvt. Ltd. dividend distribution that was paid to the parent company and a $1,730,000 deferred tax liability for the global tax exposure related to all remaining historical unremitted earnings of these international subsidiaries as of October 31, 2019. The Company will record the Dividend Distribution Tax on all future Kewaunee Labway India Pvt. Ltd. earnings at an estimated rate of 20.6% in addition to the corporate income taxes.
Noncontrolling interests related to the Company’s subsidiarysubsidiaries not 100% owned by the Company reduced net earnings by $35,000$17,000 and $120,000$42,000 for the three and ninesix months ended JanuaryOctober 31, 2018,2019, respectively, as compared to $17,000$40,000 and $98,000$49,000 for the comparable periods of the prior year. The change in the net earnings attributable to the noncontrolling interest in the current period was due to changes in earnings of the subsidiary in the related period.

Net earnings of $883,000,loss was $2,178,000, or $0.31$0.79 per diluted share, were reported for the three months ended JanuaryOctober 31, 2018,2019, compared to net earnings of $341,000,$1,332,000, or $0.13$0.48 per diluted share, in the prior year period. Net earningsloss of $3,755,000,$1,707,000, or $1.35$0.62 per diluted share, were reported for the ninesix months ended JanuaryOctober 31, 2018,2019, compared to net earnings of $3,127,000,$2,821,000, or $1.15$1.01 per diluted share, in the prior year period.

Liquidity and Capital Resources

Historically, the Company’s principal sources of liquidity have been funds generated from operations, supplemented as needed by short-term borrowings under the Company’s revolving credit facility. Additionally, certain machinery and equipment are financed bynon-cancellable operating leases. The Company believes that these sources will be sufficient to support ongoing business requirements in the current year, including capital expenditures.

The Company had working capital of $36.2 million$30,841,000 at JanuaryOctober 31, 2018,2019, compared to $32.9 million$32,624,000 at April 30, 2017.2019. The ratio of current assets to current liabilities was2.4-to-1.0 2.0-to-1.0 at JanuaryOctober 31, 2018,2019, compared to2.2-to-1.0 2.0-to-1.0 at April 30, 2017.2019. At JanuaryOctober 31, 2018,2019, advances of $4.5$6.8 million were outstanding under the Company’s bank revolving credit facility, compared to advances of $3.5$9.5 million outstanding as of April 30, 2017.2019. The Company had standby letters of credit outstanding of $4.2$344,000 at October 31, 2019 compared to standby letters of credit outstanding of $5.2 million at January 31, 2018 and April 30, 2017.2019. Amounts available under the $20 million revolving credit facility were $11.3$12.9 million and $12.3$5.3 million at JanuaryOctober 31, 20182019 and April 30, 2017,2019, respectively. Total bank borrowings and interest rate swaps were $7.5$6.9 million at JanuaryOctober 31, 2018,2019, compared to $6.9$10.9 million at April 30, 2017.

The Company’s operations used cash2019. As previously reported in the reports on Form 8-K filed by the Company on June 21, 2019 and July 11, 2019, and in Note 4 of $645,000the Notes to the Consolidated Financial Statements included in the Company's 2019 Annual Report on Form 10-K, during the ninesix months ended October 31, 2019, the Company amended its credit facility and entered into a restated security agreement.

In September 2019, the Company paid off its term loan and terminated its interest rate swap agreements.  On December 13, 2019, the Company entered into an amendment to the Loan Agreement and the Line of Credit to effect a change to an asset based lending arrangement based on eligible accounts receivable and inventory, with the available amount not to exceed $20 million through January 31, 2018. Cash2020, and with such maximum amount reduced to $15 million thereafter. This amendment replaced the prior financial covenants with new financial covenants, including minimum monthly liquidity and EBITDA requirements.  Additionally, a requirement for the repatriation of foreign cash and restrictions on the payments of dividends was primarily used to support an increaseadded.  At October 31, 2019, the Company was in receivablescompliance with all of $1,025,000 and inventoriesthe then-applicable financial covenants of $2,745,000, and a decrease in deferred revenue of $3,847,000, partially offset by cash provided by earnings and an increase in accounts payable and other accrued expenses of $2,020,000. the agreement. 
The Company’s operations provided cash of $5,851,000$4,496,000 during the ninesix months ended JanuaryOctober 31, 2017.2019. Cash was provided primarily provided from earnings,by operations and a decreasedecreases in receivables of $2,090,000, partially offset by an increase in accounts payable$1,171,000 and other accrued expensesinventory of $1,189,000.

$2,428,000. During the ninesix months ended JanuaryOctober 31, 2018,2019, the Company used net cash of $1,965,000$715,000 in investing activities, all of which included $1,907,000was used for capital expenditures, and a $58,000 increase in restricted cash. During the nine months ended January 31, 2017, net cash of $2,061,000 was used in investing activities, which included $2,190,000 for capital expenditures, offset by a $129,000 decrease in restricted cash.

expenditures. The Company’s financing activities used cash of $836,000$5,174,000 during the ninesix months ended JanuaryOctober 31, 2018,2019, primarily for reductions in short-term borrowings of $2,753,000, cash dividends of $1,331,000$1,045,000 paid to stockholders, cash dividends of $74,000 paid to minority interest holders of $89,000 and paymentsrepayments of $626,000 on$1,273,000 of long-term debt, partially offset by an increase in net short-term borrowings of $1,187,000. The Company’s financing activities used cash of $477,000 during the nine months ended January 31, 2017, primarily for cash dividends of $1,163,000 and payments on long-term debt of $316,000, partially offset by an increase in short-term borrowings of $861,000.

Financial debt.

Outlook

As disclosed in the Company’s Report on Form10-Q for the period ended October 31, 2017, on December 7, 2017, the Company experienced a criminal network cyber-attack that led to a disruption of its domestic operations, including manufacturing, engineering, administration, and sales operations. The temporary production disruption had an immaterial impact on sales and earnings for the period ended January 31, 2018, and the Company believes it will have an immaterial impact for the remainder of the fiscal year.



The Company’s ability to predict future demand for its products continues to be limited given its role as subcontractor or supplier to dealers for subcontractors. Demand for the Company’s products is also dependent upon the number of laboratory construction projects planned and/or current progress in projects already under construction. The Company’s earnings are also impacted by fluctuations in prevailing pricing for projects in the laboratory construction marketplace and increased costs of raw materials, including stainless steel, wood, and epoxy resin, and whether the Company is able to increase product prices to customers in amounts that correspond to such increases without materially and adversely affecting sales. Additionally, since prices are normally quoted on a firm basis in the industry, the Company bears the burden of possible increases in labor and material costs between the quotation of an order and delivery of a product. Looking forward, the Companythird quarter is optimistic that fiscal year 2018 will result in sales and earnings growthtypically the Company's most challenging quarter as our order backlog and opportunitiesthere are fewer manufacturing days than other quarters due to the holidays in the marketplace remain strong.

United States and construction projects generally slow down at the end of the calendar year. Our goal is to ensure that the Company's fourth quarter production load is full in order to operate our manufacturing facilitates efficiently, which in turn should drive recovery in profitability.


Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This report contains statements that the Company believes to be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this report, including statements regarding the Company’s future financial condition, results of operations, business operations and business prospects, are forward-looking statements. Words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “predict,” “believe” and similar words, expressions and variations of these words and expressions are intended to identify forward-looking statements. All forward-looking statements are subject to important factors, risks, uncertainties and assumptions, including industry and economic conditions

that could cause actual results to differ materially from those described in the forward-looking statements. Such factors, risks, uncertainties and assumptions include, but are not limited to, competitive and general economic conditions, both domestically and internationally; changes in customer demands; dependence on customers’ required delivery schedules; risks related to fluctuations in the Company’s operating results from quarter to quarter; risks related to international operations, including foreign currency fluctuations; changes in the legal and regulatory environment; changes in raw materials and commodity costs; and acts of terrorism, war, governmental action, natural disasters and other Force Majeure events. Many important factors that could cause such a differencedifferences are described under the caption “Risk Factors” in Item 1A in the Company’s 20172019 Annual Report on Form10-K and underin Quarterly Reports on Form 10-Q subsequently filed by the caption “Risk Factors” in Part II, Item 1A of both this report and the Company’s Report on Form10-Q for the period ended October 31, 2017.Company. These forward-looking statements speak only as of the date of this document. The Company assumes no obligation, and expressly disclaims any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Item 3.Quantitative and Qualitative Disclosures About Market Risk

There are no material changes to the disclosures made on this matter in the Company’s Annual Report on Form10-K for the fiscal year ended April 30, 2017.

2019.
Item 4.Controls and Procedures

(a) Evaluation of Disclosure Controlsdisclosure controls and Procedures

As of the end of the period covered by this Quarterly Report on Form10-Q, we carried out anprocedures

An evaluation was performed under the supervision and with the participation of ourthe Company’s management, including ourthe Chief Executive Officer (“CEO”) and our Chief Financial Officer (“CFO”), of the effectiveness of the design and operation of ourthe Company’s disclosure controls and procedures as(as defined in RuleRules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934.1934, as amended) as of October 31, 2019. Based on that evaluation, the evaluation, our Chief Executive OfficerCompany’s management, including the CEO and our Chief Financial Officer haveCFO, concluded that, as of October 31, 2019, the end of the period covered by this Quarterly Report on Form10-Q, ourCompany’s disclosure controls and procedures were notadequate and effective and designed to ensure that theall material information required to be disclosedfiled in this quarterly report is made known to them by usothers within the Company and its subsidiaries.
(b) Changes in internal controls
There was no significant change in the reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required financial disclosure.

As disclosed under Item 9A. Controls and Procedures in our Annual Report on Form10-K for the year ended April 30, 2017, management identified a material weakness inCompany’s internal control over financial reporting relatingthat occurred during the most recent fiscal quarter that has materially affected, or is reasonably likely to the misapplication of certain aspects ofmaterially affect, the Company’s multi-element and percentage of completion revenue recognition policies.

The Company has implemented changes to the design of its controls and procedures surrounding the execution of the Company’s multi-element and percentage of completion revenue recognition policies, which included, but were not limited to, drafting additional policy guidance, training key personnel and developing additional detective and monitoring controls. The material weakness cannot be considered remediated until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. We currently expect to complete remediation of the material weakness by April 30, 2018.

In addition, as disclosed in the Company’sForm 10-Q for the period ended October 31, 2017, on December 7, 2017, the Company experienced a criminal network cyber-attack that led to a disruption of its domestic operations, including manufacturing, engineering, administration, and sales operations. The Company engaged a leading cybersecurity firm to perform a forensic investigation of this attack and as a result of the investigation has identified a material weakness in its logical access control over its IT systems. We currently expect to complete remediation of this material weakness by April 30, 2018.

PART II. OTHER INFORMATION

Item 1A.Risk Factors

Other than as set forth below, as of January 31, 2018 there have been no material changes to the risk factors faced by the Company from those previously disclosed in our Annual Report on Form10-K for the year ended April 30, 2017, and in our Quarterly Report on Form10-Q for the period ended October 31, 2017.

Cybersecurity incidents could expose us to liability and damage our reputation and our business.

We collect, process, store, and transmit large amounts of data, and it is critical to our business strategy that our facilities and infrastructure remain secure and are perceived by the marketplace to be secure. Our information technology systems are essential to our efforts to manufacture our products, process customer sales transactions, manage inventory levels, conduct business with our suppliers and other business partners, and record, summarize and analyze the results of our operations. These systems contain, among other things, material operational, financial and administrative information related to our business. As with most companies there will always be some risk of physical or electronicbreak-ins, computer viruses, or similar disruptions.

In addition, we like all entities, are the target of cybercriminals who attempt to compromise our systems. From time to time, we experience threats and intrusions that may require remediation to protect sensitive information, including our intellectual property and personal information, and our overall business. Any physical or electronicbreak-in, computer virus, cybersecurity attack or other security breach or compromise of the information handled by us or our service providers may jeopardize the security or integrity of information in our computer systems and networks or those of our customers and cause significant interruptions in our and our customers’ operations.

Any systems and processes that we have developed that are designed to protect customer, associate and vendor information, intellectual property, and prevent data loss and other security attacks cannot provide absolute security. In addition, we may not successfully implement remediation plans to address all potential exposures. It is possible that we may have to expend additional financial and other resources to address these problems. Failure to prevent or mitigate data loss or other security incidents could expose us or our customers, associates and vendors to a risk of loss or misuse of such information, cause customers to lose confidence in our data protection measures, damage our reputation, adversely affect our operating results or result in litigation or potential liability for us. While we maintain insurance coverage that may, subject to policy terms and conditions, cover certain aspects of cyber risks, this insurance coverage is subject to a retention amount and may not be applicable to a particular incident or otherwise may be insufficient to cover all our losses beyond any retention. Similarly, we expect to continue to make significant investments in our information technology infrastructure. The implementation of these investments may be more costly or take longer than we anticipate, or could otherwise adversely affect our business operations, which could negatively impact our financial position, results of operations or cash flows.

We recently experienced a network cyber-attack that disrupted our domestic operations.

As disclosed in ourForm 10-Q for the period ended October 31, 2017, on December 7, 2017, the Company experienced a criminal network cyber-attack that led to a disruption of its domestic operations, including manufacturing, engineering, administration, and sales operations. As of December 12, 2017 the Company had restored its domestic operations. The Company engaged third party experts, including a leading cybersecurity firm, to perform a forensic investigation of this attack and as a result of the investigation has identified a material weakness in internal control over financial reporting relating to its logical access control over its IT systems. While the Company currently expects to complete remediation of this weakness by April 30, 2018, there can be no assurance that such remediation will be completed by such date. The Company has insurance coverage against recovery costs and business interruption resulting from cyber-attacks. However, the Company may have incurred, and may incur in the future, expenses and losses related to this attack that are not covered by insurance.

reporting.



PART II. OTHER INFORMATION
Item 6.Exhibits


* The referenced exhibit is a management contract or compensatory plan or arrangement.



SIGNATURE

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

KEWAUNEE SCIENTIFIC CORPORATION

(Registrant)

Date: March 9, 2018 
KEWAUNEE SCIENTIFIC CORPORATION
                             (Registrant)
Date: December 16, 2019 By

/s/ Thomas D. HullDonald T. Gardner III

 Donald T. Gardner III
 

Thomas D. Hull III

(As duly authorized officer and Vice President, Finance and Chief Financial Officer)

18


17